Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2005
Report date:
2005

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
1-methoxy-1-[(2-methylbutan-2-yl)peroxy]cyclohexane
EC Number:
700-446-2
Cas Number:
125768-93-6
Molecular formula:
C12H24O3
IUPAC Name:
1-methoxy-1-[(2-methylbutan-2-yl)peroxy]cyclohexane

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Ace Animais, Boyertown, PA
- Age at study initiation: 9-10 weeks
- Weight at study initiation: 366 - 397 grams for males and 241 - 273 grams for females
- Fasting period before study: yes
- Housing: in suspended wire mesh cages; 5/sex/cage prier to dosing and 3/sex/cage following dosing
- Diet: Fresh PMI Rat Chow, ad libitum
- Water: ad libitum
- Acclimation period:

ENVIRONMENTAL CONDITIONS
- Temperature (°C): no data
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
MAXIMUM DOSE VOLUME APPLIED: 2.08 ml/kg
Doses:
2000 mg/kg
No. of animals per sex per dose:
3
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
Animals were observed at 1/2, 1, 2, 3 & 4 hours post-dose and once daily thereafter for 14 consecutive days for mortality, toxicity & pharmacological effects.
Body Weights were recorded immediately pretest, weekly and at death or study termination in the survivors.
- Necropsy of survivors performed: yes

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD0
Effect level:
> 2 000 mg/kg bw
Remarks on result:
other: no mortality
Mortality:
Ali three male and three female animais survived the 2000 mg/kg oral dose.
Clinical signs:
Instances of localized alopecia were the only abnormal physical signs noted during the observation period.
Body weight:
Body weight changes were normal 516 animals. One female lost a slight amount of body weight
between day 7 and day 14.
Gross pathology:
Necropsy results revealed localized alopecia in two. animais and darker than normal kidneys in 5/6
animais. One animal appeared normal during necropsy.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The LD0 is > 2000 mg/kg.
Executive summary:

The potential for oral toxicity of Luperox XPS-TP was evaluated using the Acute Toxic Class Determinationfollowing the OECD Guidelines no. 423. Three healthy male and three healthy female Wistar albino rats were dosed orally with Luperox XPS-TP at 2000 mg/kg. The rats were observed 0.5, 1, 2, 3 and 4 hours postdose and once daily for 14 days for mortality, toxicity and pharmacological effects. Body weights were recorded immediately pretest, weekly and at termination. All animals were examined for gross pathology. Abnormal tissues were preserved in 10% neutral buffered formalin for possible future histological examination. All three male and three female animais survived the 2000 mg/kg oral dose. Instances of localized alopecia were the only abnormal physical signs noted during the observation period. Body weight changes were normal 5/6 animals. One female lost a slight amount of body weight between day 7 and day 14. Necropsy results revealed localized alopecia in two animals and darker than normal kidneys in 5/6 animals. One animal appeared normal during necropsy. The LD0 is > 2000 mg/kg.